Veracyte Acquires C2i Genomics, Expands Cancer Diagnostics
Key Highlights Veracyte enhances cancer diagnostics with the acquisition of C2i Genomics, integrating whole-genome MRD capabilities. Launch of muscle-invasive bladder…
Browsing Tag
C2i Genomics Inc
1 post